S Chatterjee, C Rees, D Dwarakanath, R Barton, C MacDonald, J Greenaway, W Gregory, A Reddy, D Nylander three-month period at the time of the procedures. Nurseassessed sedation and comfort levels (see Appendix I; see online material at http://www.rcpe.ac.uk/journal/issue/41-2.php for Appendices) were recorded by the endoscopist immediately after the procedures.
The BSG have published a consensus document 3 regarding consent, and details about the consent process were also collected. The endoscopists were asked to review patients immediately after the procedure and then review case notes 30 days or more after the procedure to capture immediate and delayed adverse events. In the case of an adverse event, the endoscopist reviewed the hospital records in detail to identify the type, severity and outcome of the event. The criteria for the diagnosis of post-ERCP complications are summarised in Table 2 . Anonymised patient data were analysed using the SPSS statistical software (Version 17.0 SPSS Inc).
results

Demographics of the patient population
Fourteen endoscopy units submitted data for 481 ERCP procedures. Of these, 303 procedures (63%) were carried out on females. The mean age of patients was 69 years with no difference between sexes. There were 139 patients with American Society of Anesthesiologists (ASA) grade I (mean age 60.8 years); 191 patients with grade II (mean age 71.91 years); 57 patients with grade III (mean age 77.88 years); and six patients with grade IV (mean age 80.5 years). A total of 88 questionnaires did not contain a record of patient ASA scores (see Appendix II).
Sedation
All but three procedures (which were performed with general anaesthesia) were performed with conscious . The opioids pethidine and fentanyl were used (usually in conjunction with benzodiazepine) in 310 (65%) and 145 (30%) procedures respectively. Table 3 summarises the drugs used in all procedures. Buscopan was used in 385 (81%) procedures; mean dosage 27 mg (range 10-100 mg). No patient required reversal of benzodiazepine or opiate. In our patient population, 17% (82 patients) received additional throat spray along with sedation. This group did not suffer any additional complications related to the concurrent usage of sedation and throat spray.
Consent
Information regarding consent was available in 474 out of 481 procedures. Seven questionnaires did not document any information about the process of consent. Signed consent forms were available prior to the patient reaching the endoscopy suite/x-ray department in 415 patients (86.3%), and 59 patients (12.3%) had their consent process completed by the clinician performing the ERCP just prior to the procedure.
Investigations and pre-ERCP imaging
Coagulation profile results were available on 469 patients (97%), all less than seven days prior to the procedure. In the remaining questionnaires, there was no record of this having been checked. Platelet count was available in 466 patients (97%) and 15 questionnaires had missing data. Mean prothrombin time (PT) was 13.1 seconds (range 12-30) and mean platelet count was 308 (range 58-962).
Ultrasound of the abdomen was the most frequent radiology imaging modality performed prior to ERCP. In 390 out of 481 (82%) procedures, there was record of an ultrasound report in the notes prior to the procedure. Eighteen questionnaires had no record of radiology imaging and all these procedures involved stent removal, previous failed ERCP or stenting for bile duct injury. Table  4 summarises other radiological procedures performed in addition to transabdominal ultrasound prior to ERCP.
Indications, therapy and completion of procedure
The most common indication for ERCP in this study was choledocholithiasis (56% Table 7 gives sedation and comfort score details of all procedures. Data relating to sedation and comfort scores were missing in 12 questionnaires.
Complications
There were ten reported deaths (2% of all procedures performed) within 30 days of ERCP procedure (see Table 8 ). Other complications noted were cholangitis (four; 0.8%), pancreatitis (five; 1%), bleeding (five; 1%), perforation (one; 0.2%), abdominal pain requiring hospital admission in nine patients (1.8%), hepatic abscess in one patient (0.2%), thought to be as a result of ascending cholangitis post-procedure.
dIscussIon
This is the first audit of the current practice of ERCP in DGHs in North East England. It was arranged via NREG. Fourteen hospitals participated in the study which represents 95% of all endoscopists providing ERCP service in this region.
For the purposes of this study, ERCP was deemed 'complete' only if the intended intervention was fully performed. In certain situations, when this could not be completed but the endoscopist was able to do an intermediate intervention as a bridge to the final procedure at a later date (e.g. insertion of CBD stent when the duct could not be cleared of stones) it was termed 'incomplete but with successful therapy or palliation'. Deep cannulation of the bile duct was said to have been achieved when the distal CBD was entered sufficiently to be able to attempt the intended treatment.The minimum acceptable deep cannulation rate for a trained endoscopist for grade I ERCPs is between 80-90%. 3, 4 The UK Joint Advisory group on Gastrointestinal Endoscopy has indicated that to be accredited as an independent ERCP endoscopist, an individual must show satisfactory completion of the intended therapeutic procedure in grade I ERCPs in more than 80% of cases. 3 In our study, the selective deep bile duct cannulation rate was 87.3% (420 out of 481). The total completion rate (see Table 5 ) for all procedures was 80.2% (381 out of 475) and completion of therapy was 89.5% (425 out of 475); both of which meet the standards set by JAG.
Most of the patients were either ASA grade I or II (a total of 330 out of 393 patients, 84 %). Only 63 patients (16%) were ASA grade III or IV. This reflects appropriate patient selection and is in sharp contrast to the NCEPOD report 2 that had inferred that potentially large numbers of inappropriate procedures are being carried out on 'high-risk' patients. There was no documentation of ASA grading in 88 questionnaires as three endoscopy units in the region did not routinely assess ASA grading.
There was a general supposition by the NCEPOD 2 which was also noted by Williams et al.
1 that ERCP is performed without appropriate checks such as clotting and radiological investigations. In this study, the converse was the case. Only 18 patients did not have documented imaging prior to ERCP and all of them were patients who had a previous ERCP and had come for either a stent removal or second attempt at therapy and repeat radiological investigations were not indicated. All patients had coagulation parameters checked prior to the procedure. Now predominantly a therapeutic procedure, the diagnostic role of ERCP has been superseded by other radiological modalities. In this current study, all patients underwent ERCP with a therapeutic intent and 318 (72%) had some therapeutic intervention done. This is in keeping with the current belief that ERCP should not be routinely used for diagnostic purposes. In our study, the most common indication for ERCP was choledocholithiasis with most of the procedures being difficulty grade I (427 of 475; 90%).
The complication rates of ERCP have been studied in great detail previously both in the UK and in the United States.
1 Our study reported an overall complication rate of 5% which is similar to previous reports. [5] [6] [7] [8] [9] [10] The 30-day mortality rate was 2% (10 patients) amongst all procedures performed. Four patients died of progressive malignancy within 30 days of the procedure. The other six deaths were all related to complications of the patients' medical condition, and there were no deaths as a direct result of the ERCP procedure itself such as bleeding, perforation, newly induced sepsis, or pancreatitis. This mortality rate and risk of complications are comparable to previously published data from the UK and North America. [5] [6] [7] [8] [9] Our study did not demonstrate a correlation between rate of complication with either the difficulty of the procedure or with ASA grade of the patient (p=0.8). This observation is due to correct patient selection (only a few patients were of ASA grade III and IV) and more difficult ERCPs (grade As there are no universally accepted comfort and sedation scoring systems, we used systems which were agreed by all the authors prior to the commencement of the audit (see Appendix I). The BSG has recommended 11 that the mean dosage of midazolam for ERCP should be less than 5 mg (3.24 mg in our study) and adverse events, such as usage of flumazenil for reversal of sedation should be recorded (not used in any of our patients in this study). This, we feel should be interpreted in conjunction with the sedation and discomfort scores and procedure times. Mean procedure time was 24 minutes with only 2.7% patients getting a sedation and comfort score of more than III.
This study faced some limitations. Firstly, some of the audit questionnaires were incomplete. Secondly, the study failed to investigate the influence of trainees on ERCP lists. In North East England since the publication of the BSG audit 1 there has been a definite move towards training only a few nominated registrars (as per its recommendations) and there was no trainee performing or being trained in ERCP during the study period. Thirdly, it was not possible to compare the performance of participating centres due to a possibility of different case mix and small numbers of procedures in this study. Also, the number of procedures performed by each endoscopist was too small to make an individual assessment of their performance.
It is well known that publication of national audits gives us much needed insight into our daily practice. Deliberate introduction of practice changes in the post-audit era help us improve, and follow-up audits like this current one reassure ourselves of continued compliance with national standards. We believe that this audit has effectively reported current practice of ERCP in DGHs in North East England. It is clear that their endoscopy units have incorporated the findings (which have been audited in this study) of the NCEPOD enquiry report 2 into their daily practice, to enable them to deliver the safest patient care. 
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